(Q27000393)

main subject

arterial hypertension

1 reference

Zeenat Safdar

1

1 reference

Sonja Bartolome

series ordinal

2

1 reference

Norman Sussman

series ordinal

3

1 reference

language of work or name

1 reference

August 2012

1 reference

published in

Liver Transplantation

1 reference

volume

18

1 reference

issue

8

1 reference

page(s)

881-91

1 reference

Updated clinical classification of pulmonary hypertension.

cites work

1 reference

Pulmonary complications in cirrhosis

21 January 2018

1 reference

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.

21 January 2018

1 reference

Portopulmonary hypertension and right heart failure in patients with cirrhosis

21 January 2018

1 reference

Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups

21 January 2018

1 reference

Severe pulmonary hypertension in liver transplant candidates

21 January 2018

1 reference

Portopulmonary hypertension: a report from the US-based REVEAL Registry.

21 January 2018

1 reference

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial

21 January 2018

1 reference

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

21 January 2018

1 reference

Portopulmonary hypertension: Results from a 10-year screening algorithm.

21 January 2018

1 reference

Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature

21 January 2018

1 reference

Hepatopulmonary syndrome following portopulmonary hypertension

21 January 2018

1 reference

Rapid progression from hepatopulmonary syndrome to portopulmonary hypertension in an adolescent female with hypopituitarism.

21 January 2018

1 reference

Clinical risk factors for portopulmonary hypertension

21 January 2018

1 reference

Serotonin transporter polymorphisms in patients with portopulmonary hypertension

21 January 2018

1 reference

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease

21 January 2018

1 reference

Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations

21 January 2018

1 reference

Pulmonary hypertension in chronic liver disease

21 January 2018

1 reference

Hemodynamics and survival of patients with portopulmonary hypertension

21 January 2018

1 reference

Portopulmonary hypertension and the issue of survival

21 January 2018

1 reference

Evolving dilemmas and management of portopulmonary hypertension

21 January 2018

1 reference

Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.

21 January 2018

1 reference

Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation

21 January 2018

1 reference

Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan.

21 January 2018

1 reference

Severe pulmonary hypertension and amelioration of hepatopulmonary syndrome after liver transplantation.

21 January 2018

1 reference

Targeted Oral Therapies in the Treatment of Pulmonary Arterial Hypertension

21 January 2018

1 reference

Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs

21 January 2018

1 reference

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Advances in prostanoid infusion therapy for pulmonary arterial hypertension

21 January 2018

1 reference

Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension

21 January 2018

1 reference

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

21 January 2018

1 reference

Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension

21 January 2018

1 reference

Rapid normalization of portopulmonary hypertension after living donor liver transplantation.

21 January 2018

1 reference

Use of inhaled epoprostenol in transition to extubation in a patient after implantation of a ventricular assist device.

21 January 2018

1 reference

Beraprost therapy for pulmonary arterial hypertension

21 January 2018

1 reference

Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension

21 January 2018

1 reference

Bosentan therapy for portopulmonary hypertension

21 January 2018

1 reference

Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension.

21 January 2018

1 reference

Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension

21 January 2018

1 reference

Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation

21 January 2018

1 reference

Long-term vardenafil therapy improves hemodynamics in patients with pulmonary hypertension

21 January 2018

1 reference

Tadalafil in primary pulmonary arterial hypertension

21 January 2018

1 reference

Sildenafil treatment for portopulmonary hypertension

21 January 2018

1 reference

Milrinone. A preliminary review of its pharmacological properties and therapeutic use.

21 January 2018

1 reference

Rapid assessment and safe management of severe pulmonary hypertension with milrinone during orthotopic liver transplantation

21 January 2018

1 reference

Pulmonary Arterial Hypertension

21 January 2018

1 reference

Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database

21 January 2018

1 reference

Successful outcomes following living donor liver transplantation for portopulmonary hypertension

21 January 2018

1 reference

Natural history of hepatopulmonary syndrome: Impact of liver transplantation

21 January 2018

1 reference

Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective

21 January 2018

1 reference

Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension).

21 January 2018

1 reference

Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis.

21 January 2018

1 reference

Pulmonary-Hepatic vascular Disorders (PHD).

21 January 2018

1 reference

Experience with inhaled iloprost and bosentan in portopulmonary hypertension

21 January 2018

1 reference

release_kt6pknuxpzbc3lowadrzijf4bi

21 January 2018

Identifiers

DOI

10.1002/LT.23485

0 references

Fatcat ID

0 references

PubMed publication ID

22674534

1 reference